Neurol. praxi. 2012;13(1):14-16

Mediaction overuse headache

MUDr.Jolana Marková
Neurologická klinika TN, Praha

Medication overuse headache belongs to the group of chronic daily headache (CDH). When some of the serious secondary headaches,

such as brain tumour, cerebrovascular disease or other diseases caused by a structural lesion of the central nervous system, are ruled out,

in typical migraine sufferers CDH may develop by transformation from episodic to chronic migraine, or it may be primary chronic tension-

type headache, and/or the headache may result from overuse of medications (medication overuse headache, MOH). In the latter case,

there is primarily an interaction between an excessively used acute analgesic drug and a predisposed type of patient. It has been shown

that frequent and regular use of analgesic-antipyretic drugs, nonsteroidal anti-inflammatory drugs (NSAIDs), ergotamine agents, triptans,

opioids or combinations of these drugs may result in drug-induced headache, and not in pain relief. This condition can be managed by withdrawal

of the overused medication, detoxification, and initiation of both adequate prophylaxis and appropriate acute treatment. Successful

treatment requires the patient’s motivation and the physician’s persistent supervision and feedback. The article presents the opinion of an

expert who deals with this problem in the practice and describes experience from the author’s workplace.

ergotamine, treatment.

Keywords: medication overuse headache, classification, pain chronification, analgesics, nonsteroidal anti-inflammatory drugs, triptans,

Published: February 14, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marková J. Mediaction overuse headache. Neurol. praxi. 2012;13(1):14-16.
Download citation

References

  1. Creach Ch. Medication overuse headaches more complex with triptan plus other meds. headache 2009; 49: 519-528. Go to original source... Go to PubMed...
  2. Dodick DW. Clinical practise. Chronic daily headache. N Engl J Med. 2006; 354(2): 158-165. Go to original source... Go to PubMed...
  3. Evers S, Jensen R. Treatment of medication overuse headache- guidelines of the EFNS headache panel. Eur J Neurol 2011; 18: 115-1121. Go to original source... Go to PubMed...
  4. Headache Classification Subcommittee of the International Heaeache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24(Suppl 1): 1-160.
  5. Marková J, Mastík J, Doležil D, Dočekal P, Niedermayerová I, Rejda J, Kotas R, Lánská V. Nadužívání léků pacienty s chronickou denní bolestí hlavy v České Republice. Cesk Slov Neurol N. 2011; 74/107(1): 67-71.
  6. Meng I, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: Insights and hypotheses from precilinical studies. Cephalalgia 2011; 3: 851-860. Go to original source... Go to PubMed...
  7. Opavský J, Keller O, Kotas R, Mastík J, Marková J, Rejda J, Waberžinek G. Česká verze revidované Mezinárodní klasifikace bolestí hlavy navržené a předložené Mezinárodní společnosti pro bolesti hlavy. Cesk Slov Neurol N 68/101, 2005; No.2, p. 133-138.
  8. Sun-Edelstein C, Bigal ME, Rapoport AM. Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria. Cephalalgia 2009; 29: 445-452. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.